Table 3. Baseline characteristics of the 99 patients undergoing at least 1 cycle of CHT, related to cardiac risk factors and comorbidities, laboratory values and cardiac evaluation before treatment.

Abbreviations: BMI, body mass index; BNP, brain natriuretic peptide; CHT, chemotherapy; LVEF, left ventricular ejection fraction; NS, not significant; RAS, renin‐angiotensin system; TDI, tissue doppler imaging.